Cited by

• Extra virgin olive oil improved body weight and insulin sensitivity in high fat diet-induced obese LDLr-/-.Leiden mice without attenuation of steatohepatitis.

  Álvarez-Amor L, Sierra AL, Cárdenas A, López-Bermudo L, López-Beas J, Andújar E, Pérez-Alegre M, Gallego-Durán R, Varela LM, Martin-Montalvo A, Berná G, Rojas A, Robles-Frías MJ, Hmadcha A, Romero-Gómez M, Kleemann R, Martín F. Álvarez-Amor L, et al. Sci Rep. 2021 Apr 15;11(1):8250. doi: 10.1038/s41598-021-87761-3. Sci Rep. 2021. PMID: 33859314 Free PMC article.
• Metabolic Spectrum of Liver Failure in Type 2 Diabetes and Obesity: From NAFLD to NASH to HCC.

  Kim H, Lee DS, An TH, Park HJ, Kim WK, Bae KH, Oh KJ. Kim H, et al. Int J Mol Sci. 2021 Apr 26;22(9):4495. doi: 10.3390/ijms22094495. Int J Mol Sci. 2021. PMID: 33925827 Free PMC article. Review.
• Circulating AIM as an indicator of liver damage and hepatocellular carcinoma in humans.

  Yamazaki T, Mori M, Arai S, Tateishi R, Abe M, Ban M, Nishijima A, Maeda M, Asano T, Kai T, Izumino K, Takahashi J, Aoyama K, Harada S, Takebayashi T, Gunji T, Ohnishi S, Seto S, Yoshida Y, Hiasa Y, Koike K, Yamamura K, Inoue K, Miyazaki T. Yamazaki T, et al. PLoS One. 2014 Oct 10;9(10):e109123. doi: 10.1371/journal.pone.0109123. eCollection 2014. PLoS One. 2014. PMID: 25302503 Free PMC article.
• Nonalcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis: Current Issues and Future Perspectives in Preclinical and Clinical Research.

  Berardo C, Di Pasqua LG, Cagna M, Richelmi P, Vairetti M, Ferrigno A. Berardo C, et al. Int J Mol Sci. 2020 Dec 17;21(24):9646. doi: 10.3390/ijms21249646. Int J Mol Sci. 2020. PMID: 33348908 Free PMC article. Review.
• Gut microbiota and their metabolites in the progression of non-alcoholic fatty liver disease.

  Zhou J, Tripathi M, Sinha RA, Singh BK, Yen PM. Zhou J, et al. Hepatoma Res. 2021 Jan 13;7:11. doi: 10.20517/2394-5079.2020.134. eCollection 2021. Hepatoma Res. 2021. PMID: 33490737 Free PMC article.